NSCLC Clinical Trials in Miami, Florida

4 studies are recruiting for nsclc in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or metastatic solid tumors harboring a TP53 Y220C mutation. The Phase 1 portion of the study will assess the safety, toler…

    Stage
    Phase 1
    Ages
    12 and older
    Site
    University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida
    Locations
    77 in total
    Run by
    PMV Pharmaceuticals, Inc

    See if you can join NCT04585750 on ClinicalTrials.gov

  2. First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

    The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safety of TUB-030. The main questions it aims to answer are: To determine the safety and tolerability of TUB-030 To determine the maximum tolerated dose of TUB-030 …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Miami, Miami, Florida
    Locations
    20 in total
    Run by
    Tubulis GmbH

    See if you can join NCT06657222 on ClinicalTrials.gov

  3. A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies

    The aim of this study is to assess the safety, side effects and effectiveness of EP0031 (Lunbotinib) in patients with advanced RET-altered non-small cell lung cancer (NSCLC) in monotherapy and in combination with standard of care (SOC) chemotherapy.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida
    Locations
    52 in total
    Run by
    Ellipses Pharma

    See if you can join NCT05443126 on ClinicalTrials.gov

  4. A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

    The purpose of this study is to see whether adding liver stereotactic ablative radiotherapy/L-SABR to standard drug therapy is better than standard drug therapy alone for people with metastatic non-small cell lung cancer/NSCLC.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    BAPTIST ALLIANCE - MCI (Data Collection Only), Miami, Florida
    Locations
    9 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT05657873 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.